EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting Role of Interleukin‐33 in Determining the Development and Severity of Atopic Dermatitis

Ali-Reza Ghasemiyeh, Marzieh Heidarzadeh Arani, Fatemeh Riazian, Ali Aghajani, Mohammad Javad Azadchehr, Hossein Motedayyen iD

Immunity, Inflammation and Disease · 2026-02 · 14 (2)

DOI: 10.1002/iid3.70351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 08.02.2026. Verfasst von Ali-Reza Ghasemiyeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran. Hauptthemen laut MEDLINE: Interleukin-33, Dermatitis, Atopic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kashan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Atopic dermatitis (AD), also referred to as atopic eczema, is one of the most common immunological disorders in children. Previous studies have suggested potential roles of interleukin‐33 (IL‐33) in the onset and progression of AD. This study investigated whether serum IL‐33 levels in children with AD are associated with disease severity, immunoglobulin E (IgE) sensitization to food or environmental allergens, and serum IgE concentration.

Methods

The study included 62 children with newly diagnosed AD and 30 age‐matched healthy controls. Following an interview and confirmation of disease severity, 3mL of venous blood was collected from each participant. Sensitization to allergens was assessed using a skin prick test. Serum IL‐33 (ng/L) and IgE (IU/mL) levels were measured using enzyme‐linked immunosorbent assay (ELISA).

Results

Among the 62 children with AD, 51 (82.3%) were sensitized to food allergens, whereas 11 (17.7%) were sensitized to environmental allergens. Most patients (75.8%) had mild AD. Serum IL‐33 and IgE levels were significantly elevated in patients compared with healthy controls. Both IL‐33 and IgE concentrations were significantly associated with moderate AD. However, IL‐33 levels were not correlated with age, gender, or allergen type. Receiver operating characteristic (ROC) analysis revealed that IgE levels demonstrated moderate diagnostic performance for AD (AUCc0.758), while IL‐33 showed weaker diagnostic value (AUC = 0.678). For predicting disease severity, IL‐33 exhibited strong performance, with the highest sensitivity (85.71%) and maximum specificity (70.21%) at a cut‐off of 331.32 ng/L (AUC = 0.862). In contrast, IgE was not a reliable predictor of AD severity.

Conclusion

Serum IL‐33 levels are significantly correlated with AD severity and may serve as a predictive biomarker, whereas IgE shows limited utility for severity assessment. Further studies are warranted to validate the clinical applicability of IL‐33 in AD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33Dermatitis, AtopicHumansMaleFemaleImmunoglobulin ESeverity of Illness IndexChild, PreschoolChildBiomarkersAllergensCase-Control StudiesInfantSkin TestsROC CurveAdolescent

Stichwörter der Autor:innen

atopic dermatitisdisease severityenvironmental allergensfood allergensimmunoglobulin E (IgE)interleukin‐33 (IL‐33)

Substanzen

Interleukin-33Immunoglobulin EIL33 protein, humanBiomarkersAllergens

Autor:innen und Institutionen

  • Pediatric Department, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
  • Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  • Clinical Diagnostic Laboratory, Matini Hospital, Kashan University of Medical Sciences, Kashan, Iran.
  • Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
  • Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.

ORCID-Profile: Hossein Motedayyen

Förderung

  • Kashan University of Medical Sciences

Zitieren

APA

Ghasemiyeh, A. R., Arani, M. H., Riazian, F., Aghajani, A., Azadchehr, M. J., & Motedayyen, H. (2026). Predicting Role of Interleukin‐33 in Determining the Development and Severity of Atopic Dermatitis. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70351

Vancouver

Ghasemiyeh AR, Arani MH, Riazian F, Aghajani A, Azadchehr MJ, Motedayyen H. Predicting Role of Interleukin‐33 in Determining the Development and Severity of Atopic Dermatitis. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70351

BibTeX
@article{Ghasemiyeh2026,
  author = {Ghasemiyeh, Ali-Reza and Arani, Marzieh Heidarzadeh and Riazian, Fatemeh and Aghajani, Ali and Azadchehr, Mohammad Javad and Motedayyen, Hossein},
  title = {Predicting Role of Interleukin‐33 in Determining the Development and Severity of Atopic Dermatitis},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {2},
  doi = {10.1002/iid3.70351}
}
Kostenlos starten →